Schedule 13G ownership disclosure

ANIKA THERAPEUTICS INC

Security class unavailable · CUSIP: 035255108

Event date: 2017-08-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
11.4900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001140361-17-030564
Form type
SC 13G
Filer
Anika Therapeutics, Inc.
CIK
CIK 898437
Filed
Aug 08, 2017
Reporting period
Aug 08, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub